Exercise may keep cancer patients healthier during, after treatment – Breast and prostate cancer patients who regularly exercise during and after cancer treatment report having a better quality of life and being less fatigued, according to researchers at Henry Ford Hospital in Detroit.
Estrogen-lowering drugs minimize surgery in breast cancer patients – A US study has confirmed the benefit of giving estrogen-lowering drugs before surgery to breast cancer patients. The treatment increased the likelihood that women could undergo breast-conservation surgery, also called lumpectomy, instead of mastectomy.
Delaying post-surgical radiation increases risk of breast cancer recurrence in older women – Older women who have had breast cancer surgery have a greater risk of the cancer returning if they delay their post-surgical radiation treatment, report Dana-Farber Cancer Institute scientists.
Personalizing cancer: Creating biomarkers from tumor DNA – Researchers have developed a new technique for tracking cancer by identifying personalized biomarkers from tumor DNA, reports a new study in the 24 February 2010 issue of the journal Science Translational Medicine, published by AAAS, the nonprofit science society.
Genes found linked to breast cancer drug resistance could guide future treatment choices – Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.
Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy – Using Herceptin with chemotherapy clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher.
Scientists uncover new key to the puzzle of hormone therapy and breast cancer – The decreased use of postmenopausal hormone therapy has played a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer, revealed by researchers.
FDA-approved drugs fulvestrant and raloxifene eliminate, prevent cervical cancer in mice. – Researchers eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis. The study is published in the Proceedings of the National Academy of Sciences.
Breast density associated with increased risk of cancer recurrence — Study finds higher risk of cancer recurrence in women with dense breasts. – Women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts, revealed by researchers in a study published in the Cancer — journal of the American Cancer Society.
MRI may be unnecessary prior to treatment in most newly diagnosed breast cancer patients — New Study in Journal of the American College of Surgeons Finds Those Who Undergo MRI More Likely to Have Premature Mastectomy. – New research findings published in the August issue of the Journal of the American College of Surgeons challenge the routine use of magnetic resonance imaging (MRI) as a means to improve surgical outcomes in newly diagnosed breast cancer patients.
